Pharmacogenomics in advanced pharmacy practice experiences

Huston, Sally A.; Zdanowicz, Martin M.; Fetterman, James W.

doi:10.1016/j.cptl.2010.07.004

Cited by 7 publications

(18 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[12][13][14]16 Although the literature typically refers to these barriers, a detailed understanding is generally lacking and it is likely that the relative importance and drivers of these issues may vary between countries because of differences in health and education systems. 12,16,17 There has also been a lack of investigation about issues such as how pharmacists would prefer to be educated about this subject, whether pharmacists are prepared to take on PG roles and whether there are barriers to expanding the roles of pharmacists in general. 7,12,17,18 The views of hospital pharmacists are particularly important as PG is likely to have more immediate applications in the hospital setting.…”

Section: Introductionmentioning

confidence: 99%

Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia

2013

View full text Add to dashboard Cite

There is little literature regarding the barriers to the uptake of pharmacogenomics (PG) in pharmacy practice, especially with respect to Australia. To date, pharmacists have seldom been engaged in discussions of these issues. This study aimed to obtain an in-depth understanding of these barriers by interviewing pharmacists in Adelaide, South Australia. Ethics approved semistructured interviews were carried out with 21 public hospital pharmacists. Analysis of the data identified themes including: confidence to engage in PG, clinician acceptance of a pharmacist PG role, and the importance of timely and relevant PG education. Interviewees thought that pharmacists could have a greater participation in PG in the future, but they questioned whether this would be possible at the moment given, among other factors, existing time and work constraints.

show abstract

Section: Introductionmentioning

confidence: 99%

Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia

2013

View full text Add to dashboard Cite

show abstract

“…Further, pharmacy students may dismiss human genomics topics as being unimportant for current pharmacy practice, seeing it as a future trend [5,8,12]. Importantly, there appear to be no guidelines for pharmacy educators regarding what type of pharmacogenomics preparation pharmacy students require for clinical practice or how it should be integrated into the curriculum [1,15,28,29]. This is a broad issue however and applies equally to other emerging scientific disciplines including nanotechnology, cell therapies and biopharmaceutical development.…”

Section: Barriers To Pharmacogenomics Educa-tionmentioning

confidence: 94%

“…Current educators of pharmacy might also not be sufficiently trained in pharmacogenomics [6,10,15,25]. Educators may believe that their own knowledge of genomics is poor [1]. Those who have decided to teach genomics may have conceded that this is a challenge due to the complexity of the field -in fact, the efforts and resources required to teach and learn genomics should not be underestimated [13,15,25].…”

Section: Barriers To Pharmacogenomics Educa-tionmentioning

confidence: 97%

“…Further research in this area is required, to address the question of how the pharmacy profession may be able to take on roles involving pharmacogenomics. More recent literature has begun to depict the results of surveys evaluating practicing pharmacists' knowledge, education and perceptions of the pharmacogenomics field [1,29,40,41]. However, there is still a need to assess pharmacists' views on their ability to help implement pharmacogenomic tests and services [34].…”

Section: Pharmacogenomics Education For the Practice Of Personalized mentioning

confidence: 98%

“…With the advent of genomic technology, a more specific focus on pharmacogenomics education in pharmacy school curricula has been evident for more than a decade. By 2002, the American Association of Colleges of Pharmacy (AACP) had made specific recommendations for the pharmacogenomics training of students [1][2][3]. In 2005, the International Society of Pharmacogenomics (ISP) addressed their guidelines for the pharmacogenomics education of health professionals to the deans of the schools of pharmacy, medicine, and nursing [4,5].…”

Section: Pharmacists' Pharmacogenomics Edu-cation and Knowledgementioning

confidence: 99%

See 2 more Smart Citations

Reforming Pharmaceutical Education to Enhance the Global Uptake of Pharmacogenomics and Personalized Medicine

Dias¹,

Depala²,

Ward³

et al. 2012

CPPM

View full text Add to dashboard Cite

Personalized medicine has been defined as the tailoring of medical treatment based on individual patient characteristics. In practice, personalized medicine generally involves the stratifying of patient populations based on biomarkers, most frequently genetic in nature. This results in patient subpopulations likely to show differential responses to drug therapy in terms of efficacy and toxicity. While the potential for personalized medicine to positively impact on drug discovery and therapeutics has been widely hyped, clinical uptake has been markedly limited. Over the recent years, a number of potential barriers to the more widespread uptake of personalized medicine have been identified. These include technical, economic and social factors. One such barrier is the need for the significant up-skilling of health professionals in order to harness the potential of personalized medicine and ensure adequate information flow to consumers. Pharmacists are ideally positioned to be active participants in personalized medicine but to date, their role has been minimal. While the reasons are multifactorial, we argue that there is a clear need for significant reforming of current pharmacy curricula. Here we review progress in worldwide pharmaceutical education and practice relevant to global personalized medicine and public health pharmacogenomics and highlight salient points for future consideration.

show abstract

Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review

Wondrasek,

Fryza,

Aziz

et al. 2024

Health Science Reports

View full text Add to dashboard Cite

Background and AimsPharmacists have been recognized as one of the most qualified healthcare professionals in the clinical implementation of pharmacogenomics, yet its widespread implementation in clinical pharmacy practice has remained limited. The review aims to systematically investigate knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students to inform the future delivery of pharmacogenomics education programs.MethodsPubMed, MEDLINE, Embase, Scopus, and the International Pharmaceutical Abstracts were searched up to May 17, 2022. Studies were selected if they included data on pharmacists' or pharmacy students' knowledge, perception, or attitude about pharmacogenomics and were published in a peer‐reviewed, English‐language journal with full‐text availability. Any published study not deemed original research was excluded. All included studies were critically appraised using the Center for Evidence‐Based Management's critical appraisal tools. The data were descriptively analyzed and presented based on pharmacists' and pharmacy students' knowledge/awareness, perception/attitudes toward pharmacogenomic (PGx), confidence in using or interpreting PGx testing results, and their desire to get further PGx education or their most preferred method of further education.ResultsA combined total of 12,430 pharmacists and pharmacy students from 26 countries are represented in the 52 included studies. Despite overwhelmingly positive attitudes and perceptions toward pharmacogenomics among pharmacists and pharmacy students, an overall lack of adequate knowledge and confidence was found. The review also found a strong desire for further pharmacogenomics education among pharmacists and pharmacy students.ConclusionPharmacists and pharmacy students have positive perceptions and attitudes toward pharmacogenomics, which is hindered by a lack of knowledge and confidence. However, inadequate control for confounders, limited representativeness of the studied population or region, and small sample sizes diminish the generalizability of the review results. Knowledge and confidence could be improved through enhanced delivery of pharmacogenomic courses within the pharmacy curriculum and continuing education programs.

show abstract

Pharmacogenomics in advanced pharmacy practice experiences

Cited by 7 publications

References 3 publications

Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia

Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia

Reforming Pharmaceutical Education to Enhance the Global Uptake of Pharmacogenomics and Personalized Medicine

Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review

Contact Info

Product

Resources

About